1-7 of 7
Vivek Subbiah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation–positive hairy cell leukemia

Clinical Trials & Observations
Robert J. Kreitman, Philippe Moreau, Farhad Ravandi, Martin Hutchings, Anas Gazzah, Anne-Sophie Michallet, Zev A. Wainberg, Alexander Stein, Sascha Dietrich, Maja J. A. de Jonge, Wolfgang Willenbacher, Jacques De Grève, Evgeny Arons, Palanichamy Ilankumaran, Paul Burgess, Eduard Gasal, Vivek Subbiah
Journal: Blood
Blood (2023) 141 (9): 996–1006.
https://doi.org/10.1182/blood.2021013658
Published: 2023
Includes: Supplemental data
Journal Articles

Treatment with Combination of Dabrafenib and Trametinib in Patients with Recurrent/Refractory BRAF V600E-Mutated Hairy Cell Leukemia (HCL)

Robert J. Kreitman, MD, Philippe Moreau, Martin Hutchings, MD, Anas Gazzah, MD, Jean-Yves Blay, MD PhD, Zev A. Wainberg, MD, Alexander Stein, MD, Sascha Dietrich, MD, Maja J.A. de Jonge, MD, Wolfgang Willenbacher, MD, Jacques De Greve, MD, Evgeny Arons, PhD, Farhad Ravandi, MD, Fatima Rangwala, Paul Burgess, Bijoyesh Mookerjee, Vivek Subbiah, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 391.
https://doi.org/10.1182/blood-2018-99-113135
Published: 2018
Journal Articles

Vemurafenib in Patients with Erdheim-Chester Disease (ECD) and Langerhans Cell Histiocytosis (LCH) Harboring BRAF V600 Mutations: A Cohort of the Histology-Independent VE-Basket Study

Eli L. Diamond, Vivek Subbiah, Craig Lockhart, Jean-Yves Blay, Jason E. Faris, Igor Puzanov, Ian Chau, Noopur S. Raje, Jürgen S. Wolf, Joe Erinjeri, Jean Torrisi, Gary Ulaner, Mario Lacouture, Susan Robson, Martina Makrutzki, Elena Elez, Josep Tabernero, Omar Abdel-Wahab, MD, Jose Baselga, David M. Hyman
Journal: Blood
Blood (2016) 128 (22): 480.
https://doi.org/10.1182/blood.V128.22.480.480
Published: 2016
Journal Articles

The Efficacy of Vemurafenib in Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Preliminary Results from VE-Basket Study

David M. Hyman, MD, Eli Diamond, Vivek Subbiah, MD, Jean-Yves Blay, MD PhD, A. Craig Lockhart, Omar Abdel-Wahab, MD, Florin Sirzen, Maria Luisa Veronese, MD, Susan Frances Laserre, Elena Elez, Jose Baselga, MD PhD
Journal: Blood
Blood (2014) 124 (21): 635.
https://doi.org/10.1182/blood.V124.21.635.635
Published: 2014
Journal Articles

Significant Activity Of The mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat In Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Filip Janku, MD, PhD, Ignacio Garrido-Laguna, MD, Vivianne Velez-Bravo, Gerald S. Falchook, MD, Vivek Subbiah, MD, David S. Hong, MD, Yasuhiro Oki, MD, Jason R. Westin, MD, Cesar A. Nunez, M.D., Luis E Fayad, Larry W. Kwak, MD, PhD, Elizabeth J Shpall, MD, Jennifer J. Wheler, MD, Winnie Liang, PhD, Bodour Salhia, PhD, Funda Meric-Bernstam, MD, Razelle Kurzrock, Michelle Fanale, MD
Journal: Blood
Blood (2013) 122 (21): 3048.
https://doi.org/10.1182/blood.V122.21.3048.3048
Published: 2013
Journal Articles

Analyses of Prognostic Factors for Survival in East African Patients with AIDS-Related Non-Hodgkin’s Lymphoma (AR-NHL) Treated with Dose Modified Oral Chemotherapy.

Vivek Subbiah, MD, O.W. Mwanda, MD, Jackson Orem, MD, P. Fu, C. Banura, J. Kakembo, A. Ness, J. Johnson, J. Bako, E. Katongole-Mbidde, Scot Remick, MD
Journal: Blood
Blood (2006) 108 (11): 3862.
https://doi.org/10.1182/blood.V108.11.3862.3862
Published: 2006
Journal Articles

Clinical Features of Patients with T Cell Large Granular Lymphocyte Leukemia Distinguish Patients with Splenomegaly and Those Who Benefit from Splenectomy.

Vivek Subbiah, MD, A. Al-kali, MD, M. Wlodarski, Z. Nearman, G. Ramsingh, MD, S. Rosenblatt, MD, A. Lichtin, MD, Jaroslaw P. Maciejewski, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 4467.
https://doi.org/10.1182/blood.V108.11.4467.4467
Published: 2006